Anavex Life Sciences Corp (AVXL)

[Investor2014]

I am too.

I am surprised Missling has not initiated a larger study.

Because it was strongly intimated here:

Alzheimer’s disease: Full data ANAVEX®2-73-AD-004, including newly available preliminary results of surrogate biomarkers of pivotal Phase 2b/3 clinical trial. The Company intends to discuss these findings with regulatory authorities in the context of the ongoing clinical development of ANAVEX®2-73 in this indication, with the goal of providing a much-needed treatment to the millions of patients living with Alzheimer’s disease with a convenient once-daily oral treatment. The Company plans to proceed in parallel with the initiation of a confirmatory Alzheimer’s disease study.

Since Anavex had heard from some KOL that they could get away with using the OLE as the confirmatory trial - doubtful.

Now we are instead waiting in hopeful anticipation for who knows how long for Anavex to file an EMA MAA for full approval in AD from the P2b/3 trial. The constant for Anavex is change.